Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 4/20 | 0.59 |
| ▸ | CES2 | O00748 | 4/20 | 0.57 |
| ▸ | CES1 | P23141 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL816636 | 0.93 | CES2 (0.58) | PTGS2CES2CES1ALDH1A1ESR1 | |
| SCHEMBL1581395 | 0.91 | CES2 (0.59) | PTGS2CES2CES1NAAA | |
| SCHEMBL18045476 | 0.91 | CES2 (0.59) | PTGS2CES2CES1NAAA | |
| SCHEMBL19642160 | 0.91 | CES2 (0.59) | PTGS2CES2CES1NAAA | |
| SCHEMBL815938 | 0.91 | CES2 (0.59) | PTGS2CES2CES1NAAA | |
| SCHEMBL5968483 | 0.91 | CES2 (0.59) | PTGS2CES2CES1NAAA | |
| SCHEMBL4453742 | 0.91 | CES2 (0.59) | PTGS2CES2CES1NAAA | |
| SCHEMBL2761831 | 0.91 | CES2 (0.59) | PTGS2CES2CES1NAAA | |
| SCHEMBL11494540 | 0.91 | CES2 (0.59) | PTGS2CES2CES1NAAA | |
| SCHEMBL3281895 | 0.88 | L3MBTL1 (0.44) | PTGS2CES2CES1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7247687-B2 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-07-24 | — | — | US | claimed |
| EP-1521758-B1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2006-05-24 | — | — | EP | claimed |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-03-02 | — | — | US | claimed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | claimed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | claimed |
| US-10662259-B2 | Glycogen-based water solubility enhancers | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2020-05-26 | — | — | US | disclosed |
| EP-2981557-B1 | GLYCOGEN-BASED WATER SOLUBILITY ENHANCERS | ACRAF (IT) | 2020-02-05 | — | — | EP | disclosed |
| EP-1960411-B1 | HALOGEN SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2016-08-31 | — | — | EP | disclosed |
| US-20160068615-A1 | GLYCOGEN-BASED WATER SOLUBILITY ENHANCERS | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A. F. S.p.A. (IT) | 2016-03-10 | — | — | US | disclosed |
| EP-2981557-A1 | GLYCOGEN-BASED WATER SOLUBILITY ENHANCERS | Aziende Chimiche Riunite Angelini Francesco A.C.R. (IT) | 2016-02-10 | — | — | EP | disclosed |
| US-9163046-B2 | Process for producing substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-10-20 | — | — | US | disclosed |
| WO-2014161815-A1 | GLYCOGEN-BASED WATER SOLUBILITY ENHANCERS | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2014-10-09 | — | — | WO | disclosed |
| US-4822506-A | Lubricant additives containing sulfur | CIBA-GEIGY CORPORATION (US) | 1989-04-18 | — | — | US | disclosed |
| EP-0271437-A1 | Sulphurized lubricant additives | CIBA-GEIGY AG (CH) | 1988-06-15 | — | — | EP | disclosed |
| EP-0031792-B1 | POLYESTER COMPOSITIONS HAVING A REDUCED CORROSIVE EFFECT ON METALS, AND THEIR USE | CIBA-GEIGY AG (CH) | 1985-07-31 | — | — | EP | disclosed |
| US-4373044-A | REDUCING CORROSIVE ACTION ON METALS OR ALLOYS BY INCLUDING AEROSOL OF AN OXIDE | CIBA-GEIGY CORPORATION (US) | 1983-02-08 | — | — | US | disclosed |
| EP-0031792-A2 | Polyester compositions having a reduced corrosive effect on metals, and their use | CIBA-GEIGY AG (CH) | 1981-07-08 | — | — | EP | disclosed |
| EP-0016722-A1 | Stabilised flame-resistant plastics moulding composition and process for stabilising plastics made flame-resistant with organic bromine compounds | CIBA-GEIGY AG (CH) | 1980-10-01 | — | — | EP | disclosed |
| US-3988378-A | ANTISTATIC AGENTS, STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1976-10-26 | — | — | US | disclosed |
| US-3936422-A | Anti-static modified thermoplastics | CIBA-GEIGY CORPORATION (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662259-B2 | Glycogen-based water solubility enhancers | GYS2, GYS1, PYGL | PTGS2 2959/4885CES2 348/4885CES1 266/4885 |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | MLX, LOX, LMTK3 | PTGS2 3242/4885CES2 4281/4885CES1 4486/4885 |
| US-20160068615-A1 | GLYCOGEN-BASED WATER SOLUBILITY ENHANCERS | GYS2, GYS1, PYGL | PTGS2 2959/4885CES2 348/4885CES1 266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.